Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.
Year: 1997
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W1928933522
